Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Labib Haddad

Vascular & Interventional Radiology Saint Louis, MO Medical Doctor

NPI 1609839133 CMS profile 344601

615 S New Ballas Rd, Dept Of Radiology, Saint Louis, MO 63141

Open in the dashboard

General payments

$643,186

730 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$7,528 paid to institutions, not to them · program year 2019

Through program year 2025, Labib Haddad of Saint Louis, MO is reported in the CMS Open Payments database as having received $643,186 across 730 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $7,528 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $138,443 145
2024 General $106,449 116
2023 General $50,524 58
2022 General $93,226 123
2021 General $59,879 63
2020 General $53,748 47
2019 General $140,917 178

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Labib Haddad
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Labib Haddad were reported at $138,443. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Labib Haddad Vascular & Interventional Radiology median Middle half National median
2019 $140,917 $422 $125–$1,555 $163
2020 $53,748 $200 $68–$652 $114
2021 $59,879 $280 $99–$866 $132
2022 $93,226 $433 $137–$1,497 $149
2023 $50,524 $506 $152–$2,019 $160
2024 $106,449 $556 $175–$1,930 $164
2025 $138,443 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $346,019 380 payments
  2. Medtronic USA, Inc. $147,131 163 payments
  3. Bard Peripheral Vascular, Inc. $110,221 80 payments
  4. Becton, Dickinson and Company $19,449 10 payments
  5. Penumbra, Inc. $12,163 42 payments
  6. C. R. Bard, Inc. & Subsidiaries $4,000 1 payment
  7. Surefire Medical, Inc. $1,365 16 payments
  8. Terumo Medical Corporation $675 6 payments
  9. Stryker Corporation $414 4 payments
  10. Sirtex Medical Inc $405 8 payments
  11. Other $1,343 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $388,023 102 payments
  2. Consulting Fee $127,748 30 payments
  3. Travel and Lodging $74,904 239 payments
  4. Honoraria $29,075 8 payments
  5. Food and Beverage $23,413 349 payments
  6. Education $23 2 payments
Products named General payments · program years 2019–2025
  1. KYPHON EXPRESS II KYPHOPAK TRAY $192,437 162 payments
  2. OSTEOCOOL RF ABLATION Neuro Pain (includes Interventional) $77,387 77 payments
  3. OSTEOCOOL RF ABLATION SYSTEM $61,665 91 payments
  4. KYPHON Balloon Kyphoplasty Neuro Pain (includes Interventional) $59,399 72 payments
  5. INTELLIS ADAPTIVESTIM $28,381 67 payments
  6. KYPHON Balloon Kyphoplasty Neuro Pain (includes Interventional) $21,974 15 payments
  7. OSTEOCOOL RF ABLATION Neuro Pain (includes Interventional) $12,921 10 payments
  8. RIALTO $9,896 11 payments
  9. CONCERTOTM $5,497 10 payments
  10. Indigo System $5,191 22 payments
  11. Other $15,417 116 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 101 billing codes

Paid by Medicare

$67,221

Medicare's payments for the services billed

Medicare patients

955

Average age 74

Services billed

1,341

520 women, 435 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 60%
Chronic kidney disease 42%
Ischemic heart disease 40%
Diabetes 38%
COPD 34%
Cancer 33%
Depression 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

730 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record